type here...

CATEGORIES

Medication

LATEST

1234Page 2 of 4

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

John Whyte MD -
“You need to lose weight.”   Doctors say that to patients every day.  What they don’t do is tell patients how to do it.  That’s...

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD -
Several previous studies have concluded that SSRIs can significantly reduce the risk of depression. However, a recent study refutes this.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories